• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

及其主要生物活性化学成分的心脏保护作用。

The Cardioprotective Effect of and Its Major Bioactive Chemical Constituents.

作者信息

Olas Beata

机构信息

Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.

出版信息

Int J Mol Sci. 2025 May 5;26(9):4380. doi: 10.3390/ijms26094380.

DOI:10.3390/ijms26094380
PMID:40362616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12072210/
Abstract

The genus has been found to exhibit different biological properties, including antioxidant, anticancer, and others. For example, is a classical traditional herb used in various Asian countries, especially China, South Korea, and Japan. Magnolia bark is the main medicinal part of this plant. This paper reviews the current state of knowledge regarding the bark and its active constituents, especially magnolol and honokiol, with a special emphasis on their cardioprotective activity in various models. This review paper also sheds new light on the cardioprotective mechanisms of magnolol and honokiol. However, their cardioprotective potential is limited to animal in vivo models and in vitro models. Only a single study has examined the cardiovascular properties of extract in obese mice. In addition, there is no clinical evidence for the absorption and bioavailability of extracts and their main bioactive compounds in humans. Moreover, there are no studies simultaneously comparing the activity of magnolol and honokiol. Therefore, there is a need for such studies. There are also no recommendations regarding their effective or safe doses for prophylaxis and the treatment of CVDs.

摘要

已发现该属植物具有不同的生物学特性,包括抗氧化、抗癌等。例如,它是一种在亚洲各国,尤其是中国、韩国和日本使用的传统经典草药。厚朴树皮是这种植物的主要药用部位。本文综述了关于厚朴树皮及其活性成分,特别是厚朴酚与和厚朴酚的现有知识状态,特别强调了它们在各种模型中的心脏保护活性。这篇综述文章还为厚朴酚与和厚朴酚的心脏保护机制提供了新的见解。然而,它们的心脏保护潜力仅限于动物体内模型和体外模型。仅有一项研究考察了厚朴提取物在肥胖小鼠中的心血管特性。此外,没有临床证据表明厚朴提取物及其主要生物活性化合物在人体中的吸收和生物利用度。而且,没有研究同时比较厚朴酚与和厚朴酚的活性。因此,需要开展此类研究。对于它们预防和治疗心血管疾病的有效或安全剂量也没有相关建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/12072210/09184cb28678/ijms-26-04380-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/12072210/09184cb28678/ijms-26-04380-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/12072210/09184cb28678/ijms-26-04380-g001.jpg

相似文献

1
The Cardioprotective Effect of and Its Major Bioactive Chemical Constituents.及其主要生物活性化学成分的心脏保护作用。
Int J Mol Sci. 2025 May 5;26(9):4380. doi: 10.3390/ijms26094380.
2
Effect and mechanism of Magnolia officinalis in colorectal cancer: Multi-component-multi-target approach.厚朴在结直肠癌中的作用及机制:多成分-多靶点方法
J Ethnopharmacol. 2025 Feb 10;338(Pt 1):119007. doi: 10.1016/j.jep.2024.119007. Epub 2024 Oct 28.
3
Magnolol and honokiol account for the anti-spasmodic effect of Magnolia officinalis in isolated guinea pig ileum.厚朴酚与和厚朴酚是厚朴在离体豚鼠回肠中产生抗痉挛作用的原因。
Planta Med. 2008 Mar;74(4):381-4. doi: 10.1055/s-2008-1034320.
4
Bioactive polar compounds from stem bark of Magnolia officinalis.厚朴茎皮中的生物活性极性化合物。
Fitoterapia. 2012 Mar;83(2):356-61. doi: 10.1016/j.fitote.2011.11.020. Epub 2011 Dec 4.
5
A honokiol-enriched Magnolia officinalis Rehder & E.H. Wilson. bark extract possesses anxiolytic-like activity with neuroprotective effect through the modulation of CB1 receptor.一种富含厚朴酚的厚朴树皮提取物具有类似抗焦虑的活性,并通过调节CB1受体发挥神经保护作用。
J Pharm Pharmacol. 2021 Aug 12;73(9):1161-1168. doi: 10.1093/jpp/rgab067.
6
Isolation of anti-Saprolegnia lignans from Magnolia officinalis and SAR evaluation of honokiol/magnolol analogs.从厚朴中分离抗 Saprole gnia 木脂素及厚朴酚/和厚朴酚类似物的 SAR 评价。
Bioorg Med Chem Lett. 2019 Feb 1;29(3):389-395. doi: 10.1016/j.bmcl.2018.12.038. Epub 2018 Dec 17.
7
Bioinspired Honokiol Analogs and Their Evaluation for Activity on the Norepinephrine Transporter.受生物启发的厚朴酚类似物及其对去甲肾上腺素转运体活性的评价。
Molecules. 2018 Oct 4;23(10):2536. doi: 10.3390/molecules23102536.
8
Using Lignans from Bark in the Assessment of the Quality of Dietary Supplements-The Application of H NMR and HPLC-DAD.利用树皮中的木脂素评估膳食补充剂的质量——核磁共振氢谱和高效液相色谱-二极管阵列检测法的应用
Int J Mol Sci. 2025 Feb 15;26(4):1659. doi: 10.3390/ijms26041659.
9
Delivery of Magnolia bark extract in nanoemulsions formed by high and low energy methods improves the bioavailability of Honokiol and Magnolol.通过高能和低能方法形成的纳米乳液递送厚朴树皮提取物可提高和厚朴酚与厚朴酚的生物利用度。
Eur J Pharm Biopharm. 2025 Mar;208:114627. doi: 10.1016/j.ejpb.2025.114627. Epub 2025 Jan 4.
10
Magnolol from Magnolia officinalis inhibits Neopestalotiopsis ellipsospora by damaging the cell membrane.厚朴酚通过破坏细胞膜抑制椭圆孢拟盘多毛孢。
Sci Rep. 2024 Oct 22;14(1):24934. doi: 10.1038/s41598-024-75310-7.

本文引用的文献

1
Using Lignans from Bark in the Assessment of the Quality of Dietary Supplements-The Application of H NMR and HPLC-DAD.利用树皮中的木脂素评估膳食补充剂的质量——核磁共振氢谱和高效液相色谱-二极管阵列检测法的应用
Int J Mol Sci. 2025 Feb 15;26(4):1659. doi: 10.3390/ijms26041659.
2
Delivery of Magnolia bark extract in nanoemulsions formed by high and low energy methods improves the bioavailability of Honokiol and Magnolol.通过高能和低能方法形成的纳米乳液递送厚朴树皮提取物可提高和厚朴酚与厚朴酚的生物利用度。
Eur J Pharm Biopharm. 2025 Mar;208:114627. doi: 10.1016/j.ejpb.2025.114627. Epub 2025 Jan 4.
3
Honokiol and magnolol: A review of structure-activity relationships of their derivatives.
厚朴酚与和厚朴酚:其衍生物构效关系的综述。
Phytochemistry. 2024 Jul;223:114132. doi: 10.1016/j.phytochem.2024.114132. Epub 2024 May 5.
4
Recent advances of honokiol:pharmacological activities, manmade derivatives and structure-activity relationship.厚朴酚的最新进展:药理活性、人工衍生物及构效关系。
Eur J Med Chem. 2024 Jun 5;272:116471. doi: 10.1016/j.ejmech.2024.116471. Epub 2024 Apr 30.
5
The natural compounds, Magnolol or Honokiol, promote adipose tissue browning and resist obesity through modulating PPARα/γ activity.天然化合物厚朴酚或和厚朴酚通过调节 PPARα/γ 活性促进脂肪组织棕色化,抵抗肥胖。
Eur J Pharmacol. 2024 Apr 15;969:176438. doi: 10.1016/j.ejphar.2024.176438. Epub 2024 Feb 24.
6
The rich pharmacological activities of Magnolia officinalis and secondary effects based on significant intestinal contributions.厚朴的丰富药理活性及其基于重要肠道贡献的次要作用。
J Ethnopharmacol. 2021 Dec 5;281:114524. doi: 10.1016/j.jep.2021.114524. Epub 2021 Aug 13.
7
Honokiol: A review of its pharmacological potential and therapeutic insights.和厚朴酚:药理学潜力及治疗见解综述。
Phytomedicine. 2021 Sep;90:153647. doi: 10.1016/j.phymed.2021.153647. Epub 2021 Jul 16.
8
Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update.厚朴酚的药理学、毒性、生物利用度及制剂:最新进展
Front Pharmacol. 2021 Mar 17;12:632767. doi: 10.3389/fphar.2021.632767. eCollection 2021.
9
Honokiol/Magnolol-Loaded Self-Assembling Lecithin-Based Mixed Polymeric Micelles (MPMs) for Improving Solubility to Enhance Oral Bioavailability.姜烯酚/厚朴酚载药自组装磷脂基混合聚合物胶束(MPMs)提高溶解度以增强口服生物利用度。
Int J Nanomedicine. 2021 Jan 26;16:651-665. doi: 10.2147/IJN.S290444. eCollection 2021.
10
Thin-layer chromatographic quantification of magnolol and honokiol in dietary supplements and selected biological properties of these preparations.膳食补充剂中美朴酚和厚朴酚的薄层色谱定量分析及其制剂的部分生物学特性
J Chromatogr A. 2020 Aug 16;1625:461230. doi: 10.1016/j.chroma.2020.461230. Epub 2020 May 30.